# US 2015/0174344 A1 · Inhalation therapy device for use in premature babies and infants

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2015/0174344 A1
- Document ID: US20150174344A1
- Status: Published application
- Kind: A1
- Application number: 14/635,362
- Filed: 2015-03-02
- Published: 2015-06-25
- Earliest claimed: 2006-02-10
- Assignees: PARI Pharma GmbH
- Applicants: PARI Pharma GmbH
- Inventors: Stefan Minocchieri; Thomas Gallem; Martina Vogelmann
- Web page: https://patentgrep.com/patent/US20150174344A1

## CPC

- A61M 11/02: operated by air {or other gas} pressure applied to the liquid {or other product} to be sprayed or atomised {(sprayers for horticulture A01G, A01H; killing insects A01M; air humidifying by nozzles F24F6/14, F24F6/18; cooling by spraying F28B, F28C)}
- A61M 11/001: {Particle size control}
- A61M 11/005: {using ultrasonics (spraying or atomising liquids using ultrasonic vibrations in general B05B17/06)}
- A61M 16/00: Devices for influencing the respiratory system of patients by gas treatment, e.g. ventilators (iron lungs A61H31/02); Tracheal tubes
- A61M 16/0003: {Accessories therefor, e.g. sensors, vibrators, negative pressure}
- A61M 16/0006: {with means for creating vibrations in patients' airways}
- A61M 16/0054: {Liquid ventilation}
- A61M 16/0069: {the speed thereof being controlled by respiratory parameters, e.g. by inhalation}
- A61M 16/04: Tracheal tubes (catheters in general A61M25/00)
- A61M 16/0816: {Joints or connectors}
- A61M 16/108: {before being humidified or mixed with a beneficial agent}
- A61M 16/1085: {after being humidified or mixed with a beneficial agent}
- A61M 16/109: {the humidifying liquid or the beneficial agent}
- A61M 16/142: {with semi-permeable walls separating the liquid from the respiratory gas}
- B05B 7/0081: {Apparatus supplied with low pressure gas, e.g. "hvlp"-guns; air supplied by a fan}
- A61M 16/16: Devices to humidify the respiration air {(A61M16/1045 takes precedence)}
- A61M 16/161: {with means for measuring the humidity}
- A61M 2202/0488: Surfactant, e.g. for the lung
- A61M 2205/3327: Measuring
- A61M 2205/3368: Temperature
- A61M 2205/50: with microprocessors or computers
- A61M 2206/11: Laminar flow
- A61M 2240/00: Specially adapted for neonatal use
- B05B 17/0646: {Vibrating plates, i.e. plates being directly subjected to the vibrations, e.g. having a piezoelectric transducer attached thereto}
- A61M: DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY (introducing media into or onto the bodies of animals A61D7/00; means for inserting tampons A61F13/26; devices for administering food or medicines orally A61J; containers for collecting, storing or administering blood or medical fluids A61J1/05); DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY (surgery A61B; chemical aspects of surgical articles A61L); DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR {(Electrotherapy, e.g. producing anaesthesia by the use of alternating or intermittent currents A61N1/36021)}
- B05B: SPRAYING APPARATUS; ATOMISING APPARATUS; NOZZLES (spray-mixers with nozzles B01F25/72; processes for applying liquids or other fluent materials to surfaces by spraying B05D)

## Abstract

For use in premature babies and infants, in particular for administering surfactant to the lungs, the inhalation therapy device described herein comprises an aerosol generating device 1, a respiratory air flow generating means 3 and a nebulising chamber 5 into which the generated liquid droplets 2 and the respiratory air flow 4 are supplied. The nebulising chamber 5 comprises a tapering area 52 which ends in a tubular intubation means 6. The intubation means 6 is designed such that the intubation end 6b can be positioned in such a manner that the liquid droplet/respiratory air mixture conveyed via the intubation means is released behind those areas of the respiratory tract that filter out to a great extent the liquid droplets from the mixture.

## Claims

### Claim 1

Inhalation therapy device comprising:
an aerosol generating device having a membrane for nebulising a fluid an providing liquid droplets; and
a nebulising chamber having a respiratory air supply inlet having a center line and being configured to receive a flow of respiratory air from a ventilator and a connecting piece configured for direct connection to a patient line at an outlet, wherein the liquid droplets and the respiratory air are supplied to and mix in the nebulizing chamber to form a liquid droplet/respiratory air mixture that flows through the outlet, wherein the aerosol generating device is fixed substantially on the center line of the outlet of the nebulising chamber.

### Claim 2 (depends on 1)

Inhalation therapy device according to claim 1, wherein a center line of the air supply inlet is aligned substantially to the center line of the outlet of nebulising chamber.

### Claim 3 (depends on 1)

Inhalation therapy device according to claim 1, wherein the air supply inlet is disposed to direct the flow of respiratory air onto a rear side of the aerosol generating device.

### Claim 4 (depends on 1)

Inhalation therapy device according to claim 1, wherein a respiratory air humidifying device is provided for humidifying the respiratory air.

### Claim 5 (depends on 4)

Inhalation therapy device according to claim 4, wherein at least one humidity sensor is provided for supplying a humidity measurement signal.

### Claim 6 (depends on 1)

Inhalation therapy device according to claim 1, wherein a respiratory air pulsation device is provided to generate pressure oscillations in the respiratory air.

### Claim 7 (depends on 4)

Inhalation therapy device according to claim 4, wherein the respiratory air is humidified in phases in which no liquid droplets are generated.

### Claim 8 (depends on 1)

Inhalation therapy device according to claim 1, further comprising an aerosol generation controller for controlling said aerosol generator.

### Claim 9 (depends on 8)

Inhalation therapy device according to claim 8, wherein a respiratory air control apparatus is connected with the aerosol generation controller of the aerosol generating device.

### Claim 10 (depends on 9)

Inhalation therapy device according to claim 9, wherein the respiratory air control apparatus controls the aerosol generating device.

### Claim 12 (depends on 1)

Inhalation therapy device according to claim 1, wherein the aerosol generating device comprises a reservoir for storing the liquid to be nebulised.

### Claim 13 (depends on 1)

Inhalation therapy device according to claim 1, wherein the nebulizing chamber has a tapered area, the outlet being disposed at the end of the tapered area.

### Claim 14 (depends on 1)

Inhalation therapy device according to claim 1, wherein the aerosol generator is fixed in the nebulizing chamber by a holding device comprising a plurality of radially extending support elements for fixing the aerosol generating device.

### Claim 15 (depends on 14)

Inhalation therapy device according to claim 14, wherein the holding device comprises a plurality of separated through-holes for the respiratory air supplied to said nebulising chamber.

### Claim 16 (depends on 1)

Inhalation therapy device according to claim 1, further comprising:
a tubular intubation device,
which comprises a first end configured for connection to the connecting piece of the outlet of the nebulising chamber, and
which comprises a second end that is configured for endotracheal or endopharyngeal intubation.

### Claim 17 (depends on 16)

Inhalation therapy device according to claim 16, wherein the entire length of the tubular intubation means is not more than 50 cm.

### Claim 18 (depends on 1)

Inhalation therapy device according to claim 1, wherein no additional air stream is introduced downstream of the nebulising chamber in a direction to the patient.

### Claim 19 (depends on 1)

Inhalation therapy device according to claim 1, wherein the aerosol generating device, the outlet of the nebulising chamber and the respiratory air supply inlet of the nebulising chamber for supply of the respiratory air flow are aligned substantially along one axis and wherein the liquid droplets are provided only in a direction of the respiratory air flow.

### Claim 20 (depends on 1)

Inhalation therapy device according to claim 1, wherein the nebulising chamber has a rotationally symmetrical configuration with an axis of rotation, wherein the respiratory air supply inlet is located on the axis of rotation, and wherein the aerosol generating device is fixed in the nebulising chamber on the axis of rotation.

### Claim 21 (depends on 1)

Inhalation therapy device according to claim 1, wherein the membrane is positioned substantially on the center line of the outlet of the nebulising chamber.

### Claim 22

Inhalation therapy device comprising:
an aerosol generating device having a membrane for nebulising a fluid and providing liquid droplets; and
a nebulising chamber having a respiratory air supply inlet having a center line and being configured to receive a flow of respiratory air from a ventilator and a connecting piece configured for direct connection to a patient line at an outlet, wherein the liquid droplets and the respiratory air are supplied to and mix in the nebulizing chamber to form a liquid droplet/respiratory air mixture that flows through the outlet, wherein the aerosol generating device is fixed substantially on the center line of the air supply inlet of the nebulising chamber.

### Claim 23 (depends on 22)

Inhalation therapy device according to claim 22, wherein the aerosol generating device, the outlet of the nebulising chamber and the respiratory air supply inlet of the nebulising chamber for supply of the respiratory air flow are aligned substantially along one axis and wherein the liquid droplets are provided only in a direction of the respiratory air flow.

### Claim 24 (depends on 22)

Inhalation therapy device according to claim 22, wherein the nebulising chamber has a rotationally symmetrical configuration with an axis of rotation, wherein the respiratory air supply inlet is located on the axis of rotation, and wherein the aerosol generating device is fixed in the nebulising chamber on the axis of rotation.

### Claim 25 (depends on 22)

Inhalation therapy device according to claim 22, wherein the membrane is positioned substantially on the center line of the outlet of the nebulising chamber.

### Claim 26 (depends on 22)

Inhalation therapy device according to claim 22, wherein a center line of the outlet is aligned substantially to the center line of air supply inlet.

### Claim 27 (depends on 22)

Inhalation therapy device according to claim 22, wherein the air supply inlet is disposed to direct the flow of respiratory air onto a rear side of the aerosol generating device.

### Claim 28 (depends on 1)

Use of an inhalation therapy system according to claim 1 for the administration of anti-inflammatory agents such as steroids (Ciclesonide, Fluticasone), or non-steroidal anti-inflammatory agents (such as, for instance, Ibuprofen, Celecoxib), or betamimetic agents (such as, for instance, Indacaterol, Formoterol, Levalbuterol), or anti-cholinergic agents (such as, for instance, Thiotropium, Glycopyrrolate, Ipratropium), or phosphodiesterase inhibitors (such as, for instance, Sildenafil, Vardenafil, Tadalafil), or endothelin antagonists (such as, for example, Bosentan, Sixtasentan, Tezosentan), or leukotriene antagonists (such as, for instance, Montelukast), or diuretics (such as, for instance, Furosemide, Amiloride), or immunomodulators (such as, for instance, Cyclosporin, Mofetil, Sirolimus, Tacrolimus), or antihypertensive agents (such as, for example, Statins, Sartans, calcium and angiotension antagonists), or mucolytics (such as, for instance, Dornase alpha, Bromhexine, Ambroxol, Acetylcysteine), or antibiotics of a variety of classes such as chinolons, macrolides, cephalosporins, aminogylcosides, ketolides, peptides and proteins, or interferons, or immunoglobulins, or prostins, or antimycotics, or antiviral agents, or heparin and heparinoids, or cytostatics, or endogenous substances which, owing to a gene defect such as, for instance, mucoviscidosis, or to illness, are not available in sufficient amounts in the body, such as, for instance, alpha-antitrypsin, interferons, insulin, or a combination of the above substances.

### Claim 29 (depends on 1)

Method of administering a substance, preferably a medicament, using an inhalation therapy device according to claim 1, wherein an administration strategy is used.

### Claim 30 (depends on 28)

Method according to claim 28, wherein the administration strategy comprises a first phase, in which the aerosol generator is operated with a first output rate, and a second phase, in which the aerosol generator is operated with a second output rate, the first output rate being greater than the second output rate.

### Claim 31 (depends on 30)

Method according to claim 30, wherein the first output rate is designed for the greatest possible deposition of aerosol in the lungs and the second output rate is designed to optimise utilisation of the active substance.

### Claim 32 (depends on 30)

Method according to claim 30, wherein the first and second output rates can be applied and combined as desired in order to optimise each expedient/required administration strategy.
